Brief Summary
This research study is collecting and storing samples of tumor tissue, bone marrow, and blood from patients with Ewing sarcoma. Collecting and storing samples of tumor tissue, bone marrow, and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
Brief Title
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Detailed Description
OBJECTIVES:
I. Collect biological specimens, including associated demographic and clinical data, from patients with Ewing sarcoma.
II. Provide a repository for long-term storage of Ewing sarcoma-related biological materials.
III. Make collected specimens available to qualified researchers to understand the biology of Ewing sarcoma and correlate these results with demographic and clinical data.
OUTLINE: This is a multicenter study.
Patients undergo collection of tumor specimens, bone marrow, and peripheral blood at diagnosis. Associated demographic and clinical data are collected and archived. Patients who are not enrolled on a therapeutic clinical trial are followed annually.
I. Collect biological specimens, including associated demographic and clinical data, from patients with Ewing sarcoma.
II. Provide a repository for long-term storage of Ewing sarcoma-related biological materials.
III. Make collected specimens available to qualified researchers to understand the biology of Ewing sarcoma and correlate these results with demographic and clinical data.
OUTLINE: This is a multicenter study.
Patients undergo collection of tumor specimens, bone marrow, and peripheral blood at diagnosis. Associated demographic and clinical data are collected and archived. Patients who are not enrolled on a therapeutic clinical trial are followed annually.
Categories
Completion Date
Completion Date Type
Actual
Conditions
Askin Tumor
Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
* Newly diagnosed or recurrent disease
* Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
* Newly diagnosed or recurrent disease
Inclusion Criteria
Inclusion Criteria:
* Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
* Newly diagnosed or recurrent disease
* Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
* Newly diagnosed or recurrent disease
Gender
All
Gender Based
false
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Maximum Age
21 Years
NCT Id
NCT00899990
Org Class
Network
Org Full Name
Children's Oncology Group
Org Study Id
AEWS07B1
Overall Status
Completed
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
A COG Study for Collecting and Banking Ewing Sarcoma Specimens
Primary Outcomes
Outcome Measure
Banking of biological specimens, including associated demographic and clinical data
Outcome Time Frame
Not Provided
Secondary Ids
Secondary Id
NCI-2009-00370
Secondary Id
COG-AEWS07B1
Secondary Id
CDR0000544202
Secondary Id
AEWS07B1
Secondary Id
AEWS07B1
Secondary Id
U10CA098543
Secondary Id
UG1CA189958
Start Date
Start Date Type
Actual
Status Verified Date
First Post Date
First Post Date Type
Estimated
First Submit Date
First Submit QC Date
Study Population
All patients with either newly diagnosed or recurrent Ewing sarcoma (including peripheral PNET and Askin tumor) are eligible for AEWS07B1.
Std Ages
Child
Adult
Maximum Age Number (converted to Years and rounded down)
21
Minimum Age Number (converted to Years and rounded down)
0
Investigators
Investigator Type
Principal Investigator
Investigator Name
Lisa Gennarini
Investigator Email
lfigueir@montefiore.org
Investigator Phone